Who was studied, and how
Two numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 3 other studies
40people in the An Evaluation of Simvastatin 20 mg Plus Omacor 4 g Compared to Simvastatin 20 mg Plus Placebo in Subjects With Mixed Dyslipidemia trial, from 2006
39of them with dyslipidemia, in this paper
The trial randomly assignedassigned by chance
P-OM3 + simvastatin
placebo + simvastatin
Reported lower systolic blood pressure, no range given−5.00
Reported lower diastolic blood pressure, no range given−3.30
randomisedthe abstract, start to end
… ratio (-51% vs -37%), and systolic (-5.0 vs 0.3 mm Hg) and diastolic (-3.3 vs -1.8 mm Hg) blood pressures …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
Systolic blood pressureP-OM3 + simvastatin vs placebo + simvastatin
−5.0
Diastolic blood pressureP-OM3 + simvastatin vs placebo + simvastatin
−3.3
StatinsBlood pressure
Statins × blood pressurehelps?replicated
unlikelylikely
0.830.80 without it
← favours treatmentfavours comparator →
1 / 6